Skip to main content
. 2020 Apr 7;16:628–637. doi: 10.3762/bjoc.16.59

Table 1.

Percent inhibition of HDAC8 by hydroxamate inhibitors.

compound concentration

100 µM 10 µM 1 µM

panobinostat (n = 4)a 100 ± 0.0 100 ± 0.0 89 ± 13.4
TOI1 (n = 4) 100 ± 0.0 90 ± 21.1 44 ± 11.5
TOI2 (n = 4) 79 ± 8.1 75 ± 13.4 23 ± 26.9
TOI3-rev (n = 4) 89 ± 7.0 75 ± 26.9 37 ± 18.1
TOI4 (n = 4 @ 100 and 10 µM,
n = 3 @ 1 µM)
93 ± 8.1 89 ± 13.4 65 ± 21.4
TCAb 93 ± 14.0

an = number of replicates for the assay; btrichostatin A (TCA) as an inhibitor control.